K Faksova, D Walsh, Y Jiang, J Griffin, A Phillips, A Gentile, J C Kwong, K Macartney, M Naus, Z Grange, S Escolano, G Sepulveda, A Shetty, A Pillsbury, C Sullivan, Z Naveed, N Z Janjua, N Giglio, J Perälä, S Nasreen, H Gidding, P Hovi, T Vo, F Cui, L Deng, L Cullen, M Artama, E Weintraub, H Lu, H J Clothier, K Batty, J Paynter, H Petousis-Harris, J Buttery, S Black, A Hviid
BACKGROUND: The Global COVID Vaccine Safety (GCoVS) Project, established in 2021 under the multinational Global Vaccine Data Network™ (GVDN®), facilitates comprehensive assessment of vaccine safety. This study aimed to evaluate the risk of adverse events of special interest (AESI) following COVID-19 vaccination from 10 sites across eight countries. METHODS: Using a common protocol, this observational cohort study compared observed with expected rates of 13 selected AESI across neurological, haematological, and cardiac outcomes...
February 12, 2024: Vaccine